publication date: Nov. 2, 2012

Vol. 38, No. 41 – 

  • Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing
  • Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer
  • In Brief: Schilsky Named ASCO Chief Medical Officer

Copyright (c) 2020 The Cancer Letter Inc.